Autologous Stem Cell Transplantation for Crohn's Disease

NCT00692939 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

BIOLOGICAL: autologous CD34-selected peripheral blood stem cells transplant
DRUG: Alemtuzumab
DRUG: ATG
DRUG: Melphalan
DRUG: Thiotepa
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: G-CSF
DRUG: Mesna

Sponsor

Paul Szabolcs